Allegiance Healthcare chooses Masimo oximeter:
This article was originally published in Clinica
Allegiance Healthcare has selected the pulse oximetry sensor and signal-processing technology from privately-owned Irvine, California company, Masimo, to be incorporated into Allegiance monitors offered under its "Best Value" programme, to US hospitals. Allegiance hailed the Masimo signal-extraction pulse oximetry as giving fewer false alarms than other systems.
You may also be interested in...
After two Indian vaccine makers, Serum Institute of India and Cadila Healthcare joined the fight against COVID-19, Bharat Biotech may follow suit. Others like Hilleman have decided against it for the moment while Panacea Biotech is weighing the pros and cons of developing a SARS-CoV-2 vaccine after a sour experience with H1N1.
South Korea’s HLB has begun a new growth phase by taking over US-based clinical stage biotech firm Immunomic Therapeutics. Through the acquisition, it is poised to add new pipeline assets including a Phase II vaccine therapy for glioblastoma and proprietary lysosomal targeting technology.